Skip to main contentSkip to navigation
Sirius Investors
Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc.

THRD
NASDAQHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for THRD. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
429.40M
-34.72% over period
CAGR: -10.11%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
147.55M
-77.28% over period
CAGR: -30.95%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2025

EV/EBITDA

Potentially Cheap

6.03x

Lower EV/EBITDA can indicate attractive valuation relative to operating earnings.

EV vs Market Cap Spread

-281.86M

EV is -65.6% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -64.4 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 14.36x

Share count change in dataset: +7.85%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2024429.40M147.55M$10.2941.73M
Dec 31, 2023434.91M169.79M$10.9739.65M
Dec 31, 2022169.32M-115.22M$4.3039.38M
Dec 31, 2021
Dec 31, 2020

Enterprise Value Analysis

Price Change (Dec 2023 to Dec 2024)

The stock price has decreased from Dec 2023 to Dec 2024.
-6.20%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.84

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.22

Market Cap Change (Dec 2023 to Dec 2024)

The company's market capitalization has decreased from Dec 2023 to Dec 2024.
-1.27%

Enterprise Value Change (Dec 2023 to Dec 2024)

The company's enterprise value has decreased from Dec 2023 to Dec 2024, suggesting a decline in the company's total economic value.
-13.10%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-10.11%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-30.95%